293 related articles for article (PubMed ID: 8159665)
1. The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state.
Lantwin CB; Schlichting I; Kabsch W; Pai EF; Krauth-Siegel RL
Proteins; 1994 Feb; 18(2):161-73. PubMed ID: 8159665
[TBL] [Abstract][Full Text] [Related]
2. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the Trypanosoma cruzi trypanothione reductase.mepacrine complex.
Jacoby EM; Schlichting I; Lantwin CB; Kabsch W; Krauth-Siegel RL
Proteins; 1996 Jan; 24(1):73-80. PubMed ID: 8628734
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution.
Zhang Y; Bond CS; Bailey S; Cunningham ML; Fairlamb AH; Hunter WN
Protein Sci; 1996 Jan; 5(1):52-61. PubMed ID: 8771196
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of antimony treatment in leishmaniasis.
Baiocco P; Colotti G; Franceschini S; Ilari A
J Med Chem; 2009 Apr; 52(8):2603-12. PubMed ID: 19317451
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking of a series of peptidomimetics in the trypanothione binding site of T. cruzi trypanothione reductase.
da Rocha Pita SS; Cirino JJ; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
J Mol Graph Model; 2009 Nov; 28(4):330-5. PubMed ID: 19766515
[TBL] [Abstract][Full Text] [Related]
8. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family.
Karplus PA; Daniels MJ; Herriott JR
Science; 1991 Jan; 251(4989):60-6. PubMed ID: 1986412
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.
Trapani S; Linss J; Goldenberg S; Fischer H; Craievich AF; Oliva G
J Mol Biol; 2001 Nov; 313(5):1059-72. PubMed ID: 11700062
[TBL] [Abstract][Full Text] [Related]
11. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
12. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies.
Gallwitz H; Bonse S; Martinez-Cruz A; Schlichting I; Schumacher K; Krauth-Siegel RL
J Med Chem; 1999 Feb; 42(3):364-72. PubMed ID: 9986706
[TBL] [Abstract][Full Text] [Related]
13. Flavin reductase P: structure of a dimeric enzyme that reduces flavin.
Tanner JJ; Lei B; Tu SC; Krause KL
Biochemistry; 1996 Oct; 35(42):13531-9. PubMed ID: 8885832
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the flavin reductase component (HpaC) of 4-hydroxyphenylacetate 3-monooxygenase from Thermus thermophilus HB8: Structural basis for the flavin affinity.
Kim SH; Hisano T; Iwasaki W; Ebihara A; Miki K
Proteins; 2008 Feb; 70(3):718-30. PubMed ID: 17729270
[TBL] [Abstract][Full Text] [Related]
16. Structure of trypanothione reductase from Crithidia fasciculata at 2.6 A resolution; enzyme-NADP interactions at 2.8 A resolution.
Bailey S; Fairlamb AH; Hunter WN
Acta Crystallogr D Biol Crystallogr; 1994 Mar; 50(Pt 2):139-54. PubMed ID: 15299452
[TBL] [Abstract][Full Text] [Related]
17. X-ray structure of the ferredoxin:NADP+ reductase from the cyanobacterium Anabaena PCC 7119 at 1.8 A resolution, and crystallographic studies of NADP+ binding at 2.25 A resolution.
Serre L; Vellieux FM; Medina M; Gomez-Moreno C; Fontecilla-Camps JC; Frey M
J Mol Biol; 1996 Oct; 263(1):20-39. PubMed ID: 8890910
[TBL] [Abstract][Full Text] [Related]
18. Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductase.
Angelucci F; Miele AE; Boumis G; Dimastrogiovanni D; Brunori M; Bellelli A
Proteins; 2008 Aug; 72(3):936-45. PubMed ID: 18300227
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of NAD(P)H:flavin oxidoreductase from Escherichia coli.
Ingelman M; Ramaswamy S; Nivière V; Fontecave M; Eklund H
Biochemistry; 1999 Jun; 38(22):7040-9. PubMed ID: 10353815
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of meso-diaminopimelic acid dehydrogenase from Corynebacterium glutamicum.
Scapin G; Reddy SG; Blanchard JS
Biochemistry; 1996 Oct; 35(42):13540-51. PubMed ID: 8885833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
